As we age, the amount and distribution of fat in our bodies changes. Most fat is subcutaneous—meaning it is stored just under ...

The phrase "eye stroke" has recently appeared in news reports about a very rare side effect of weight-loss injections. It's ...

“Performance-enhancing drug use in the UK is absolutely huge now,” says Gareth Balmer, harm reduction lead at drugs support ...

Leonardo DiCaprio is the poster boy of male celebrities frequently raised in this niche conversation. Read more at ...

Cancer an its treatment can affect a man’s sex life a self-confidence. However, with the right information & timely medical ...

Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...

The Danish drugmaker said the accelerated approval was based on results from its Step Up trial, which showed 20.7% mean ...

The FDA has approved a new higher-dose version of injectable semaglutide (Wegovy HD, Novo Nordisk) for both weight loss and ...

The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

Ready to start a weight loss journey? From GLP‑1 prescriptions to costs, we break down whether Hims customized weight loss ...

Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.